• Explore /
  • Poster
  • / Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC.

Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC.

Abstract Poster

Authors

null

Sophie Cousin

Medical Oncology Department, Institut Bergonié, Bordeaux, France

Sophie Cousin , Luis G. Paz-Ares , Andrea Fülöp , Ildiko Horvath , Jose Manuel Manuel Trigo Perez , Jon Zugazagoitia , Laura Bonanno , Jose Antonio Lopez-Vilariño , Carmen Maria Kahatt , Cristian Marcelo Fernandez , Javier Gomez , Ali Hassan Zeaiter , Alejandro Navarro , Kostas N. Syrigos , Egbert Smit , Tudor-Eliade Ciuleanu , Alberto Chiappori , Rafael Lopez-Lopez , Benjamin Besse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02454972, NCT02566993

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 8591)

DOI

10.1200/JCO.2023.41.16_suppl.8591

Abstract #

8591

Poster Bd #

218

Abstract Disclosures

Similar Posters

First Author: Alejandro Navarro

First Author: Stéphane De Botton

First Author: Benjamin Besse

First Author: Luis G. Paz-Ares